drugset / Trial / NCT05494190
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
Recruiting
111 enrolled
Eye & ENT Hospital of Fudan University
Harbin Medical University Third Affiliated Hospital · collabShandong Provincial Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.
Timeline
- Start
- 2022-11-01
- Primary completion
- 2027-11
- Completion
- 2027-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 750 mg/m2 | Oral |
| Subject | Cisplatin | Other / unclassified | 60 mg/m2 | Intravenous |
| Subject | Docetaxel | Small molecule | 60 mg/m2 | Intravenous |